Oluseun Alli, MD
Interventional Cardiology · Charlotte, NCNPI 1053524967
Payments from drug & device makers
Across 1,511 payments — averaging $1504.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$1M
- Edwards Lifesciences$574K
- Abbott$479K
- BD$184K
- Medtronic$13K
- Novartis$822
- plus $6K from 31 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 594 | $1,016,215 |
| Edwards Lifesciences | 363 | $574,419 |
| Abbott | 269 | $479,475 |
| BD | 1 | $184,075 |
| Medtronic(2 entities) | 38 | $13,118 |
| Novartis | 29 | $822 |
| Johnson & Johnson | 40 | $733 |
| W. L. Gore & Associates, Inc. | 8 | $720 |
| Amgen | 18 | $588 |
| Acist Medical Systems, Inc. | 8 | $382 |
| Cardiovascular Systems Inc. | 16 | $309 |
| Kestra Medical Technology Services, Inc. | 25 | $297 |
| Recor Medical Inc | 2 | $270 |
| E.r. Squibb & Sons, L.L.C. | 17 | $264 |
| GE HealthCare | 3 | $263 |
| Biosense Webster, Inc. | 9 | $244 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 14 | $224 |
| AstraZeneca | 7 | $215 |
| Scpharmaceuticals Inc. | 5 | $162 |
| Abiomed | 4 | $160 |
| Kiniksa Pharmaceuticals International, PLC | 8 | $160 |
| Cardiva Medical, Inc. | 6 | $156 |
| Bayer | 6 | $116 |
| Davol Inc. | 1 | $92 |
| Heartflow, Inc. | 2 | $68 |
| Novo Nordisk | 3 | $61 |
| Boehringer Ingelheim | 2 | $51 |
| Chiesi USA, Inc. | 2 | $47 |
| Atricure, Inc. | 1 | $45 |
| Siemens Medical Solutions USA, Inc. | 2 | $42 |
| Bridgebio Pharma, Inc. | 2 | $41 |
| Cvrx, Inc. | 1 | $23 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $21 |
| Shockwave Medical, Inc | 1 | $19 |
| Lantheus Medical Imaging, Inc. | 1 | $19 |
| Merck | 1 | $15 |
| Philips North America LLC | 1 | $14 |
How this compares
$2,273,946 in reported general payments places this provider in the 95th percentile of 180 interventional cardiology providers in North Carolina.
See all interventional cardiology providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Charlotte
- John PasquiniCharlotte$1.3M
- Aamer QureshiCharlotte$142K
- Robert IwaokaCharlotte$91K
- Gabriel DelgadoCharlotte$79K
- Glen FandettiCharlotte$46K
- Ravish SacharRaleigh$10.1M
- George AdamsGarner$5.2M
- Paul MahoneyGreenville$3.9M
- Patrick SimpsonPinehurst$1.6M
- Matthew CavenderChapel Hill$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.